Low density lipoprotein control in patients with ischaemic heart disease

Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/50480

Title:	Low density lipoprotein control in patients with ischaemic heart disease
Authors:	Curtolo, Elisa Wirth, Francesca Xuereb, Robert G. Camilleri, Liberato Cignarella, Andrea Azzopardi, Lilian M.
Keywords:	Coronary heart disease -- Patients Low density lipoproteins -- Metabolism Statins (Cardiovascular agents) Drugs -- Prescribing Coronary heart disease -- Case studies
Issue Date:	2018-10
Publisher:	University of Malta. Department of Pharmacy
Citation:	Curtolo, E., Wirth, F., Xuereb, R. G., Camilleri, L., Cignarella, A., & Serracino-Inglott, A. (2018, October). Low density lipoprotein control in patients with ischaemic heart disease. Poster session presented at the ACCP Global Conference on Clinical Pharmacy, Seattle, Washington, USA.
Abstract:	A poster presentation regarding low density lipoprotein control in patients with ischaemic heart disease. Introduction: The 2013 ACC/AHA guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk recommend use of the appropriate intensity of statin and not a specific low density lipoprotein cholesterol (LDL-C) target. The 2016 ESC/EAS guidelines for the management of dyslipidaemias recommend a target LDL-C goal of <1.8 mmol/L or at least 50% relative reduction. Patients with hyperlipidaemia are reported to be undertreated and not attaining recommended LDL-C goals. Aims: To assess LDL-C control and statin prescribing in patients with ischaemic heart disease (IHD) according to the European guidelines.
URI:	https://www.um.edu.mt/library/oar/handle/123456789/50480
Appears in Collections:	Scholarly Works - FacM&SPha Scholarly Works - FacSciSOR

Files in This Item:

File	Description	Size	Format
Low_density_lipoprotein_control_in_patients_with_ischaemic_heart_disease_2018.pdf		316.97 kB	Adobe PDF	View/Open

Show full item record Statistics